English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105672 (86%)
Visitors : 13066916      Online Users : 583
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    ASIA unversity > 護理學院 > 護理學系 > 期刊論文 >  Item 310904400/112917


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/112917


    Title: Prognostic Value of CD1B in Localised Prostate Cancer
    Authors: CH, Lee;CH, Lee;LC, Chen;LC, Chen;CC, Yu;CC, Yu;WH, Lin;WH, Lin;VC, Lin;VC, Lin;CY, Huang;CY, Huang;TL, Lu;TL, Lu;SP, Huang;SP, Huang;鮑柏穎;Bao, Bo-Ying
    Contributors: 護理學系
    Keywords: CD antigen;CD1B;biomarker;prognosis;prostate cancer
    Date: 2019-11
    Issue Date: 2020-09-03 15:27:13 (UTC+8)
    Publisher: 亞洲大學
    Abstract: Cluster of differentiation (CD) antigens are cell surface markers used to differentiate haematopoietic cell types. These antigens are present in various malignancies and are reportedly linked to patient prognosis; however, they have not been implemented as prostate cancer progression markers. Here, we aimed to assess the impact of genetic variation in haematopoietic cell CD markers on clinical outcomes in patients with prostate cancer. An association study of 458 patients with prostate cancer was conducted to identify single-nucleotide polymorphisms in 11 candidate CD marker genes associated with biochemical recurrence (BCR) after radical prostatectomy. Identified predictors were further evaluated in an additional cohort of 185 patients. Joint population analyses showed that CD1B rs3181082 is associated with BCR (adjusted hazard ratio 1.42, 95% confidence interval 1.09-1.85, p = 0.010). In addition, rs3181082 overlapped with predicted transcriptional regulatory elements and affected CD1B expression. Furthermore, low CD1B expression correlated with poorer BCR-free survival. Our results indicated that CD1B rs3181082 confers prostate cancer progression and may help improve clinical prognostic stratification.
    Relation: International Journal of Environmental Research and Public Health
    Appears in Collections:[護理學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML30View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback